Want to join the conversation?
RBC Capital Markets analyst Scot Ciccarelli probes $KMX on CAF loan loss reserves trend for the rest of the year given unfavorable changes in 1Q17. CEO Tom Folliard says that to the extent things were to worsen or improve, $KMX would adjust accordingly, but at this point, the increase is a combination of experience in quarter vs. expectation.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.